Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News EC approves Novartis’ skin cancer therapy combo Tafinlar and Mekinist for melanoma In a significant development for melanoma treatment, the European Commission (EC) has granted Novartis approval for its combination… bypharmanewsdailySeptember 1, 2018
